Insider Trading Arrangements |
3 Months Ended |
|---|---|
|
Dec. 31, 2025
shares
| |
| Insider Trading Arrangements [Line Items] | |
| Material Terms of Trading Arrangement | On December 8, 2025, Oncology Diagnostic & Drug Development Consulting LLC, an entity controlled by Richard E. Buller, adopted a 10b5-1 plan for the sale of up to 12,000 shares of Celcuity Inc. common stock beginning March 18, 2026 through December 23, 2026. |
| Name | Richard E. Buller |
| Rule 10b51 Arrangement Adopted | true |
| Adoption Date | December 8, 2025 |
| Rule 10b51 Arrangement Adopted | false |
| Rule 10b51 Arrangement Adopted | false |
| Expiration Date | December 23, 2026 |
| Aggregate Available | 12,000 |